Maintenance venom immunotherapy

被引:3
作者
Graft, David F. [1 ]
机构
[1] Pk Nicollet Clin, Asthma & Allerg Dis, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA
关键词
venom immunotherapy; yellow jacket; honeybee; Hymenoptera;
D O I
10.1097/00130832-200208000-00011
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review Venom immunotherapy has proven to be a very effective method for the prevention of future re-sting reactions. However, initiation of the venom injection program is just the beginning. This review looks at recent papers which shed light on other issues that arise during maintenance venom immunotherapy. Recent findings Prophylactic antihistamines taken before venom injections reduce the frequency of reactions and one report suggests that they may improve efficacy. The schedule of venom injections usually does not have to be adjusted for patients who develop local reactions; a very large reaction may be the exception. Patients who react to stings should have their maintenance doses increased. Most patients are able to extend the interval between injections to 8 weeks in the third year of treatment. Two groups have proposed a maintenance interval of 12 weeks for routine use. Summary Our understanding of insect sting sensitivity continues to improve, leading to better outcomes for allergic patients.
引用
收藏
页码:359 / 362
页数:4
相关论文
共 29 条
[1]  
[Anonymous], 1990, INSECT STING ALLERGY
[2]   Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious [J].
Goldberg, A ;
Confino-Cohen, R .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (05) :902-906
[3]   DELIBERATE BEE STING CHALLENGE OF PATIENTS RECEIVING MAINTENANCE VENOM IMMUNOTHERAPY AT 3-MONTH INTERVALS [J].
GOLDBERG, A ;
CONFINOCOHEN, R ;
MEKORI, YA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (06) :997-1001
[4]   CLINICAL CORRELATION OF THE VENOM-SPECIFIC IGG ANTIBODY LEVEL DURING MAINTENANCE VENOM IMMUNOTHERAPY [J].
GOLDEN, DBK ;
LAWRENCE, ID ;
HAMILTON, RH ;
KAGEYSOBOTKA, A ;
VALENTINE, MD ;
LICHTENSTEIN, LM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 90 (03) :386-393
[5]  
Graft DF, 1998, J ALLERGY CLIN IMMUN, V101, P573, DOI 10.1016/S0091-6749(98)70161-7
[6]   WHEN TO START, WHEN TO STOP, AND WHAT TO MEASURE IN VENOM IMMUNOTHERAPY - ISSUES IN ALLERGY GRAND SEMINAR, AAAL ANNUAL-MEETING 1990 [J].
GRAFT, DF ;
REISMAN, RE ;
VALENTINE, MD ;
YUNGINGER, JW ;
GOLDEN, DBK .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (03) :409-413
[7]   VENOM IMMUNOTHERAPY DURING PREGNANCY [J].
GRAFT, DF .
NEW ENGLAND AND REGIONAL ALLERGY PROCEEDINGS, 1988, 9 (05) :563-565
[8]  
Graft DF, 1995, MONOGRAPH INSECT ALL, P73
[9]   CONTROLLED TRIAL OF IMMUNOTHERAPY IN INSECT HYPERSENSITIVITY [J].
HUNT, KJ ;
VALENTINE, MD ;
SOBOTKA, AK ;
BENTON, AW ;
AMODIO, FJ ;
LICHTENSTEIN, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (04) :157-161
[10]   BETA-ADRENERGIC BLOCKERS, IMMUNOTHERAPY, AND SKIN TESTING [J].
KAPLAN, AP ;
ANDERSON, JA ;
VALENTINE, MD ;
LOCKEY, RF ;
PIERSON, WE ;
ZWEIMAN, B ;
KALINER, MA ;
LICHTENSTEIN, LM ;
LIEBERMAN, PL ;
SETTIPANE, GA ;
SHEFFER, AL ;
YUNGINGER, JW .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (01) :129-130